AI-generated · cited to primary sources · not investment advice
The IVD business achieved a major milestone by turning PAT (Profit After Tax) positive during the year, transitioning from a growth-stage investment to a profitable engine. (3 expanding)
“The IVD business turned PAT positive during the year”
The domestic consumer business is growing exponentially, with revenue increasing nearly 4x year-over-year. It now contributes over 20% of the company's topline in its first full year of launch. (2 expanding)
“Revenue from operations: Domestic 8,704.32 (FY25) vs 2,196.35 (FY24)”
The export segment remains the largest revenue contributor but its share of total revenue has decreased as the company pivots toward domestic consumer markets. Export revenue fell from ₹14,558.81 Lacs to ₹9,357.72 Lacs. (1 contracting)
“Revenue from operations: Exports 9,357.72 (FY25) vs 14,558.81 (FY24)”
See the full cited Business Model analysis of Cupid
The risk is easing as the IVD business has already turned PAT (Profit After Tax) positive in FY25. The company has developed 15 kits and is already exporting to 5 countries while expanding domestic distribution to 25,000 chemists. (3 easing, 1 stable)
“The IVD business turned PAT positive during the year... Distributed IVD kits across six Indian states; targeting pan-India by year-end.”
The risk is easing as the company has successfully diversified its revenue streams. The B2C FMCG segment, launched in FY24, already contributes over 14% of total revenue (₹50+ Cr), and the IVD business has turned profitable. Furthermore, new high-value orders have been secured from Tanzania (₹56.91 Cr) and Brazil (₹23.07 Cr), reducing reliance on any single geography. (2 easing, 1 stable)
“Consumer business now contributes 14%+ to total revenue... Secured multiple high-value purchase orders: Government of Tanzania: ₹14.91 Cr (Jan 2025) and ₹42 Cr (Feb 2025)... Brazil Commercial Agreement: ₹23.07 Cr”
See the full cited Risk analysis of Cupid
AI-generated informational research only. ThesisLoop is not investment advice, a stock recommendation, or a guarantee of returns.